Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;26:1134-1137

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, D. H.
Right arrow Articles by Du, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, D. H.
Right arrow Articles by Du, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Hypertension. 1995;26:1134-1137.)
© 1995 American Heart Association, Inc.


Articles

Distinct Mechanisms of Upregulation of Type 1A Angiotensin II Receptor Gene Expression in Kidney and Adrenal Gland

Donna H. Wang; Yong Du

From the Department of Internal Medicine, Hypertension and Vascular Research Laboratories, University of Texas Medical Branch, Galveston.

Correspondence to Donna H. Wang, MD, The University of Texas Medical Branch, Department of Internal Medicine, Hypertension and Vascular Research Laboratories, 8.104 Medical Research Bldg, Galveston, TX 77555-1065. E-mail dwang%intmeds1@mhost.utmb.edu.

Abstract We previously demonstrated that type 1A angiotensin II (Ang II) receptor (AT1A) is the predominant renal subtype and is upregulated by a low sodium diet. We have now tested the hypothesis that upregulation of AT1A mRNA induced by sodium deficiency is renal specific and is mediated by activation of type 1 Ang II receptor (AT1). Male Wistar rats were divided into four groups (n=5 each) and treated for 2 weeks with normal sodium diet (0.5%), normal sodium plus 3 mg/kg per day losartan, low sodium diet (0.07%), or low sodium diet plus losartan. At the end of the 2 weeks, body weight and mean arterial pressure were not different among the four groups (P>.05). Plasma renin activity was elevated by losartan treatment, sodium restriction, or the combination of the two versus control (P<.05). Northern blot analysis showed that the ratio of renal AT1A to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA was increased by losartan treatment, sodium restriction, or the combination of the two versus control (P<.05). In contrast, the ratio of adrenal AT1A to GAPDH mRNA was increased only by sodium restriction versus three other groups (P<.05). Thus, sodium deficiency increases AT1A mRNA in both kidney and adrenal gland, while Ang II receptor blockade by losartan prevents low sodium–induced AT1A mRNA only in adrenal gland. We conclude that the increase in AT1A mRNA induced by sodium deficiency is not renal specific and that different mechanisms of regulation exist, ie, in adrenal gland, low sodium–induced upregulation of AT1A is dependent upon Ang II activation of the AT1 receptor, while in kidney, a non-AT1–dependent mechanism is operant.


Key Words: receptor, angiotensin II • genes • sodium • kidney • adrenal gland




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Perez-Rojas, S. Derive, J. A. Blanco, C. Cruz, L. M. de la Maza, G. Gamba, and N. A. Bobadilla
Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity
Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1020 - F1030.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. D. Imig, G. L. Navar, L.-X. Zou, K. C. O'Reilly, P. L. Allen, J. H. Kaysen, T. G. Hammond, and L. G. Navar
Renal endosomes contain angiotensin peptides, converting enzyme, and AT1A receptors
Am J Physiol Renal Physiol, August 1, 1999; 277(2): F303 - F311.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. H. Wang, A. Yao, H. Zhao, and D. J. DiPette
Distinct Mechanisms of Modulation of Angiotensin II Type I Receptor Gene Expression in Heart and Aorta
Hypertension, May 1, 1997; 29(5): 1104 - 1108.
[Abstract] [Full Text]


Home page
HypertensionHome page
F. Elijovich, H.-W. Zhao, C. L. Laffer, Y. Du, D. J. DiPette, T. Inagami, and D. H. Wang
Regulation of Growth of the Adrenal Gland in DOC-Salt Hypertension: Role of Angiotensin II Receptor Subtypes
Hypertension, January 1, 1997; 29(1): 408 - 413.
[Abstract] [Full Text] [PDF]